ID

22928

Beschreibung

Study of XL999 in Patients With Metastatic Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00277316

Link

https://clinicaltrials.gov/show/NCT00277316

Stichworte

Versionen (1)
  1. 16.06.17 16.06.17 -
Hochgeladen am

16. Juni 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Renal Cell Carcinoma NCT00277316

Englisch

Eligibility Renal Cell Carcinoma NCT00277316

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
males and females with histologically confirmed metastatic clear cell rcc
Beschreibung

Clear-cell metastatic renal cell carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C2931852
measurable disease according to response criteria for solid tumors (recist)
Beschreibung

Measurable Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
no prior systemic cytotoxic chemotherapy
Beschreibung

Cytotoxic Chemotherapy Systemic

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C0205373
subjects who have received either no prior therapy for rcc, systemic immunotherapy only (such as interleukin-2 or interferon), or one agent targeting vegf or a vegfr (eg, bevacizumab, sorafenib, or sunitinib malate) may be enrolled
Beschreibung

Renal Cell Carcinoma untreated | Immunotherapy Systemic | Interleukin-2 therapy | Interferon therapy | Pharmaceutical Preparation Targeting Vascular Endothelial Growth Factors | Pharmaceutical Preparation Targeting Vascular Endothelial Growth Factor Receptor | bevacizumab | sorafenib | sunitinib malate

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007134
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C0021083
UMLS CUI [2,2]
C0205373
UMLS CUI [3]
C0199975
UMLS CUI [4]
C0279030
UMLS CUI [5,1]
C0013227
UMLS CUI [5,2]
C1521840
UMLS CUI [5,3]
C1256770
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C1521840
UMLS CUI [6,3]
C0148199
UMLS CUI [7]
C0796392
UMLS CUI [8]
C1516119
UMLS CUI [9]
C1700685
ecog performance status of 0 or 1
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy ≥3 months
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
adequate organ and marrow function
Beschreibung

Organ function | Bone Marrow function

Datentyp

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0031843
no other malignancies within 5 years
Beschreibung

Malignant Neoplasms Other Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0332197
signed informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
radiation to ≥25% of bone marrow within 30 days of xl999 treatment
Beschreibung

Therapeutic radiology procedure Bone Marrow Percentage | XL999

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0005953
UMLS CUI [1,3]
C0439165
UMLS CUI [2]
C1541529
subjects who have received systemic anticancer therapy within 30 days of xl999 treatment
Beschreibung

cancer treatment Systemic | XL999

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205373
UMLS CUI [2]
C1541529
subjects who have not recovered to grade ≤1 or to within 10% of baseline from adverse events due to medications administered >30 days prior to study enrollment
Beschreibung

Pharmaceutical Preparations Resulting in Adverse event CTCAE Grades | Recovery Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0332294
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C1516728
UMLS CUI [2,1]
C2004454
UMLS CUI [2,2]
C0332197
history of or known brain metastases, current spinal cord compression or carcinomatous meningitis
Beschreibung

Metastatic malignant neoplasm to brain | Compression of spinal cord | Meningeal Carcinomatosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0037926
UMLS CUI [3]
C0220654
uncontrolled and/or intercurrent illness
Beschreibung

Illness Uncontrolled | Comorbidity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0009488
pregnant or breastfeeding females
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
known hiv
Beschreibung

HIV Infection

Datentyp

boolean

Alias
UMLS CUI [1]
C0019693
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Renal Cell Carcinoma NCT00277316

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Clear-cell metastatic renal cell carcinoma
Item
males and females with histologically confirmed metastatic clear cell rcc
boolean
C2931852 (UMLS CUI [1])
Measurable Disease
Item
measurable disease according to response criteria for solid tumors (recist)
boolean
C1513041 (UMLS CUI [1])
Cytotoxic Chemotherapy Systemic
Item
no prior systemic cytotoxic chemotherapy
boolean
C0677881 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
Renal Cell Carcinoma untreated | Immunotherapy Systemic | Interleukin-2 therapy | Interferon therapy | Pharmaceutical Preparation Targeting Vascular Endothelial Growth Factors | Pharmaceutical Preparation Targeting Vascular Endothelial Growth Factor Receptor | bevacizumab | sorafenib | sunitinib malate
Item
subjects who have received either no prior therapy for rcc, systemic immunotherapy only (such as interleukin-2 or interferon), or one agent targeting vegf or a vegfr (eg, bevacizumab, sorafenib, or sunitinib malate) may be enrolled
boolean
C0007134 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0199975 (UMLS CUI [3])
C0279030 (UMLS CUI [4])
C0013227 (UMLS CUI [5,1])
C1521840 (UMLS CUI [5,2])
C1256770 (UMLS CUI [5,3])
C0013227 (UMLS CUI [6,1])
C1521840 (UMLS CUI [6,2])
C0148199 (UMLS CUI [6,3])
C0796392 (UMLS CUI [7])
C1516119 (UMLS CUI [8])
C1700685 (UMLS CUI [9])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy ≥3 months
boolean
C0023671 (UMLS CUI [1])
Organ function | Bone Marrow function
Item
adequate organ and marrow function
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
Malignant Neoplasms Other Absent
Item
no other malignancies within 5 years
boolean
C0006826 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Informed Consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic radiology procedure Bone Marrow Percentage | XL999
Item
radiation to ≥25% of bone marrow within 30 days of xl999 treatment
boolean
C1522449 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C1541529 (UMLS CUI [2])
cancer treatment Systemic | XL999
Item
subjects who have received systemic anticancer therapy within 30 days of xl999 treatment
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C1541529 (UMLS CUI [2])
Pharmaceutical Preparations Resulting in Adverse event CTCAE Grades | Recovery Absent
Item
subjects who have not recovered to grade ≤1 or to within 10% of baseline from adverse events due to medications administered >30 days prior to study enrollment
boolean
C0013227 (UMLS CUI [1,1])
C0332294 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C1516728 (UMLS CUI [1,4])
C2004454 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Metastatic malignant neoplasm to brain | Compression of spinal cord | Meningeal Carcinomatosis
Item
history of or known brain metastases, current spinal cord compression or carcinomatous meningitis
boolean
C0220650 (UMLS CUI [1])
C0037926 (UMLS CUI [2])
C0220654 (UMLS CUI [3])
Illness Uncontrolled | Comorbidity
Item
uncontrolled and/or intercurrent illness
boolean
C0221423 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0009488 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding females
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Infection
Item
known hiv
boolean
C0019693 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video